C3i Profiled in Outsourced Pharma
C3i CEO Louisa Petropoulos was recently featured in Outsourced Pharma online, discussing the present and future prospects of contract research organizations and Canadian innovation, as… Read More »
Canadian innovation
C3i Center Inc. Supports the Manufacturing of the First Canadian-Made CAR-T Cell Therapy for the Treatment of Solid Tumours
An innovative treatment for advanced metastatic HER2-positive tumours has been administered to the first patient in a phase I/II clinical trial. The investigational T-cell antigen… Read More »